Cloudera Announces Pricing of Initial Public Offering, Marking its Debut as a Public Company

Cloudera Announces Pricing of Initial Public Offering, Marking its Debut as a Public Company

PR Newswire

PALO ALTO, Calif., April 27, 2017 /PRNewswire/ — Cloudera, Inc. (NYSE: CLDR), provider of the leading modern platform for machine learning and advanced analytics built on the latest open source technologies, announced the pricing of its initial public offering of 15,000,000 shares of its common stock at a price to the public of $15.00 per share. In addition, Cloudera has granted the underwriters a 30-day option to purchase up to an additional 2,250,000 shares of common stock. The shares are expected to begin trading on the New York Stock Exchange under the symbol “CLDR” on April 28, 2017. 

Morgan Stanley, J.P. Morgan, and Allen & Company LLC are acting as lead bookrunners for the offering. BofA Merrill Lynch, Citigroup, and Deutsche Bank Securities are acting as book-running managers and Stifel, JMP Securities, and Raymond James are acting as co-managers.

The offering is being made only by means of a prospectus. A copy of the final prospectus, when available, may be obtained from Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick Street, 2nd Floor, New York, NY 10014, from J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717 or by telephone at 866-803-9204 or by email at prospectus-eq_fi@jpmchase.com and from Allen & Company LLC, Attention: Prospectus Department, 711 Fifth Avenue, 10th Floor, New York New York 10022 or by telephone at 212-339-2220 or by email at dweidlein@allenco.com.

A registration statement relating to these securities has been filed with, and declared effective by, the Securities and Exchange Commission. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/cloudera-announces-pricing-of-initial-public-offering-marking-its-debut-as-a-public-company-300447800.html

SOURCE Cloudera, Inc.

CytRx Corporation Announces Proposed Public Offering of Common Stock

CytRx Corporation Announces Proposed Public Offering of Common Stock

PR Newswire

LOS ANGELES, April 27, 2017 /PRNewswire/ – CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company specializing in oncology today announced a proposed public offering of its common stock. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be consummated, or as to the actual size or terms of the offering.

H.C. Wainwright & Co. is acting as exclusive placement agent for the offering.

CytRx intends to use the net proceeds from the offering, if completed, for working capital and general corporate purposes, including clinical and regulatory activities, new drug discovery activities, and possible future strategic transactions.

The shares of common stock are being offered pursuant to an effective “shelf” registration statement on Form S-3 (File No. 333-217184) that was previously filed with the Securities and Exchange Commission (SEC) and declared effective on April 21, 2017.  The securities may be offered only by means of a prospectus. A preliminary prospectus supplement and accompanying base prospectus related to the offering have been filed with the SEC and are available on the SEC’s website at http://www.sec.gov and may also be obtained from H.C. Wainwright & Co., LLC by calling (646) 975-6996 or emailing placements@hcwco.com.  

This press release shall not constitute an offer to sell, or the solicitation of an offer to buy, nor may there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About CytRx Corporation

CytRx Corporation is a biopharmaceutical research and development company specializing in oncology. CytRx currently is focused on the clinical development of aldoxorubicin, its improved version of the widely used chemotherapeutic agent doxorubicin.  CytRx is also expanding its pipeline of oncology candidates at its laboratory facilities in Freiburg, Germany, through its LADR™ (Linker Activated Drug Release) technology platform, a discovery engine designed to leverage CytRx’s expertise in albumin biology and linker technology for the development of a new class of anti-cancer therapies.

Forward-Looking Statements

This press release contains statements that are forward-looking statements, including with respect to the completion, timing and size of the proposed public offering and the use of net proceeds of the offering. Such statements involve inherent risks and uncertainties, such as market risks and the risk that the conditions to the closing of the offering will not be satisfied and other risks detailed in CytRx’s most recent annual report filed with the SEC and current reports filed with the SEC since the filing of CytRx’s most recent annual report. All forward-looking statements are based upon information available to CytRx on the date the statements are first published. CytRx undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Company Contact:

CytRx Corporation
David J. Haen
Vice President, Business Development and Investor Relations
(310) 826-5648, ext. 304
dhaen@cytrx.com

Media Contact:

Argot Partners
Eliza Schleifstein
(973) 361-1546
eliza@argotpartners.com

Investor Relations Contact:

Argot Partners
Michelle Carroll
(212) 600-1902
michelle@argotpartners.com

 

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/cytrx-corporation-announces-proposed-public-offering-of-common-stock-300447699.html

SOURCE CytRx Corporation

Hemisphere Energy Announces Closing of its Private Placement of CDE Flow-Through Common Shares for Total Gross Proceeds of over $1.1 Million

Hemisphere Energy Announces Closing of its Private Placement of CDE Flow-Through Common Shares for Total Gross Proceeds of over $1.1 Million

Canada NewsWire

TSX-V: HME

VANCOUVER, April 27, 2017 /CNW/ - Hemisphere Energy Corporation (“Hemisphere” or the “Company”) (TSX-V: HME) is pleased to announce the closing of its previously announced non-brokered private placement offering (the “Offering”). Hemisphere issued 4,048,200 flow-through shares (“Flow-Through Shares”) at a price of $0.28 per share, which were issued on a Canadian Development Expense flow-through basis pursuant to the provisions of the Income Tax Act (Canada) for gross proceeds to the Company of $1,133,496. Hemisphere intends to use the proceeds from the Flow-Through Shares to continue development in its Atlee Buffalo Upper Mannville F and G oil pools.

The Flow-Through Shares issued under the Offering will be subject to a statutory four-month and one day hold period. While the Offering was conducted on a non-brokered basis, the Company paid cash finder’s fees in the aggregate amount of $52,974, subject to TSX-V acceptance, in accordance with the rules and policies of the TSX-V, which is equal to 6% of the proceeds sold by such finders. Such finder’s included Richardson GMP Ltd., PI Financial Corp., Raymond James Ltd., Haywood Securities Inc. and Canaccord Genuity Corp.

About Hemisphere Energy Corporation

Hemisphere Energy Corporation is a producing oil and gas company focused on developing conventional oil assets with low risk drilling opportunities. Hemisphere plans continual growth in production, reserves, and cash flow by drilling existing lands and executing strategic acquisitions.  Hemisphere trades on the TSX Venture Exchange as a Tier 1 issuer under the symbol “HME”.


Forward-looking Statements

This news release contains “forward-looking statements” that are based on Hemisphere’s current expectations, estimates, forecasts, and projections. These forward-looking statements include statements regarding Hemisphere’s use of proceeds of the Offering including Hemisphere’s plans to continue development in its Atlee Buffalo Upper Mannville F and G oil pools and other expectations, intentions and plans that are not historical fact. The words “estimates”, “projects”, “expects”, “intends”, “believes”, “plans”, or their negatives or other comparable words and phrases are intended to identify forward-looking statements. Forward-looking statements are based on a number of factors and assumptions which have been used to develop such information but which may prove to be incorrect. Although Hemisphere believes that the expectations reflected in such forward-looking statements are reasonable, undue reliance should not be placed on forward-looking statements because Hemisphere cannot give assurance that such expectations will prove to be correct. In addition to other factors and assumptions which may be identified in this press release, assumptions have been made regarding and are implicit in, among other things: the ability of Hemisphere to incur and renounce Canadian Development Expense and that all necessary and regulatory approvals will be obtained for the Offering. Readers are cautioned that the foregoing list is not exhaustive of all factors and assumptions which have been used.

The forward‐looking statements included in this news release are not guarantees of future performance and should not be unduly relied upon. Such statements, including the assumptions made in respect thereof, involve known and unknown risks, uncertainties and other factors that may cause actual results or events to defer materially from those anticipated in such forward‐looking statements including, without limitation: changes in commodity prices; changes in the demand for or supply of Hemisphere’s products, the early stage of development of some of the evaluated areas and zones; unanticipated operating results or production declines; changes in tax or environmental laws, royalty rates or other regulatory matters; changes in development plans of Hemisphere or by third party operators of Hemisphere’s properties, increased debt levels or debt service requirements; inaccurate estimation of Hemisphere’s oil and gas reserve volumes; limited, unfavourable or a lack of access to capital markets; increased costs; a lack of adequate insurance coverage; the impact of competitors; and certain other risks detailed from time‐to‐time in Hemisphere’s public disclosure documents, (including, without limitation, those risks identified in this news release and in Hemisphere’s current Annual Information Form which may be accessed under Hemisphere’s SEDAR profile at www.sedar.com).  

The forward‐looking statements contained in this news release speak only as of the date of this news release, and Hemisphere does not assume any obligation to publicly update or revise any of the included forward‐looking statements, whether as a result of new information, future events or otherwise, except as may be required by applicable securities laws.

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.


Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

SOURCE Hemisphere Energy Corporation

View original content: http://www.newswire.ca/en/releases/archive/April2017/27/c5676.html